Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2022

Open Access 01-12-2022 | Silicosis | Research

Global and national burden and trends of mortality and disability-adjusted life years for silicosis, from 1990 to 2019: results from the Global Burden of Disease study 2019

Authors: Shimin Chen, Miao Liu, Fei Xie

Published in: BMC Pulmonary Medicine | Issue 1/2022

Login to get access

Abstract

Background

Silicosis, as an important type of pneumoconiosis, leads to progressive and irreversible conditions from the beginning of inflammation and fibrosis. However, the data on the global burden of silicosis and long-term trends were limited.

Methods

Derived from the Global Burden of Disease study 2019 (online publicly available: Global Health Data Exchange), data on both crude and age-standardized rates (ASR) per 100,00 people of mortality and disability-adjusted life years (DALYs) due to silicosis was collected and analyzed. The burden and trends of mortality and DALYs due to silicosis was assessed by 204 countries and territories, by 5-year interval of age group and by sex from 1990 to 2019. And all the regions were divided into 5 categories according to Sociodemographic Index (SDI). Temporal trends in mortality and DALY were evaluated only to ASR by the Joinpoint regression model.

Results

More than 12.9 thousand [95% Uncertainty Intervals (UI): 10.9, 16.2] death cases occurred due to silicosis worldwide, and 655.7 thousand (95% UI: 519.3, 828.0) DALYs were attributed to silicosis in 2019. From 1990 to 2019, global number of mortality and DALYs in countries with high SDI quintile decreased by 0.35% (95% UI: − 0.45, − 0.17) and 0.32% (95% UI: − 0.45, − 0.01), respectively. There was a greater burden in low- and middle-income countries were estimated in 2019 according to ASRs. The global number of mortality and DALYs among males accounted for over 95% of all in 2019. Both age-sex-specific mortality and DALY rate were increasing with aging and reached their peak at 85–89 age group. During the past 30 years, ASR of mortality and DALYs showed a decreasing trend with average annual percentage change at -3.0% [95% Confidence Intervals (CI): − 3.2, − 2.9] and − 2.0 (95% CI: − 1.7, − 2.2), respectively.

Conclusions

Silicosis remains an important health issue and causes a potentially serious burden worldwide. Attention should be paid to making preventable, affordable and effective measures in lower SDI regions.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Hoy RF, Chambers DC. Silica-related diseases in the modern world. Allergy. 2020;75(11):2805–17.CrossRef Hoy RF, Chambers DC. Silica-related diseases in the modern world. Allergy. 2020;75(11):2805–17.CrossRef
3.
go back to reference The Lancet Respiratory M: The world is failing on silicosis. Lancet Respir Med. 2019; 7(4):283. The Lancet Respiratory M: The world is failing on silicosis. Lancet Respir Med. 2019; 7(4):283.
4.
go back to reference Riley L, Urbine D. Chronic silicosis with progressive massive fibrosis. N Engl J Med. 2019;380(23):2256.CrossRef Riley L, Urbine D. Chronic silicosis with progressive massive fibrosis. N Engl J Med. 2019;380(23):2256.CrossRef
5.
go back to reference Park R, Rice F, Stayner L, Smith R, Gilbert S, Checkoway H. Exposure to crystalline silica, silicosis, and lung disease other than cancer in diatomaceous earth industry workers: a quantitative risk assessment. Occup Environ Med. 2002;59(1):36–43.CrossRef Park R, Rice F, Stayner L, Smith R, Gilbert S, Checkoway H. Exposure to crystalline silica, silicosis, and lung disease other than cancer in diatomaceous earth industry workers: a quantitative risk assessment. Occup Environ Med. 2002;59(1):36–43.CrossRef
6.
go back to reference Merget R, Bauer T, Küpper HU, Philippou S, Bauer HD, Breitstadt R, Bruening T. Health hazards due to the inhalation of amorphous silica. Arch Toxicol. 2002;75(11–12):625–34.CrossRef Merget R, Bauer T, Küpper HU, Philippou S, Bauer HD, Breitstadt R, Bruening T. Health hazards due to the inhalation of amorphous silica. Arch Toxicol. 2002;75(11–12):625–34.CrossRef
7.
go back to reference Wang H, Zhou S, Liu Y, Yu Y, Xu S, Peng L, Ni C. Exploration study on serum metabolic profiles of Chinese male patients with artificial stone silicosis, silicosis, and coal worker’s pneumoconiosis. Toxicol Lett. 2022;356:132–42.CrossRef Wang H, Zhou S, Liu Y, Yu Y, Xu S, Peng L, Ni C. Exploration study on serum metabolic profiles of Chinese male patients with artificial stone silicosis, silicosis, and coal worker’s pneumoconiosis. Toxicol Lett. 2022;356:132–42.CrossRef
8.
go back to reference León-Jiménez A, Hidalgo-Molina A, Conde-Sánchez M, Pérez-Alonso A, Morales-Morales JM, García-Gámez EM, Córdoba-Doña JA. Artificial stone silicosis: rapid progression following exposure cessation. Chest. 2020;158(3):1060–8.CrossRef León-Jiménez A, Hidalgo-Molina A, Conde-Sánchez M, Pérez-Alonso A, Morales-Morales JM, García-Gámez EM, Córdoba-Doña JA. Artificial stone silicosis: rapid progression following exposure cessation. Chest. 2020;158(3):1060–8.CrossRef
9.
go back to reference Qi XM, Luo Y, Song MY, Liu Y, Shu T, Liu Y, Pang JL, Wang J, Wang C. Pneumoconiosis: current status and future prospects. Chin Med J (Engl). 2021;134(8):898–907.CrossRef Qi XM, Luo Y, Song MY, Liu Y, Shu T, Liu Y, Pang JL, Wang J, Wang C. Pneumoconiosis: current status and future prospects. Chin Med J (Engl). 2021;134(8):898–907.CrossRef
10.
go back to reference Barnes H, Goh NSL, Leong TL, Hoy R. Silica-associated lung disease: an old-world exposure in modern industries. Respirology. 2019;24(12):1165–75.CrossRef Barnes H, Goh NSL, Leong TL, Hoy R. Silica-associated lung disease: an old-world exposure in modern industries. Respirology. 2019;24(12):1165–75.CrossRef
11.
go back to reference Yates DH, Perret JL, Davidson M, Miles SE, Musk AW. Dust diseases in modern Australia: a discussion of the new TSANZ position statement on respiratory surveillance. Med J Aust. 2021;215(1):13-15.e11.CrossRef Yates DH, Perret JL, Davidson M, Miles SE, Musk AW. Dust diseases in modern Australia: a discussion of the new TSANZ position statement on respiratory surveillance. Med J Aust. 2021;215(1):13-15.e11.CrossRef
12.
go back to reference Shi P, Xing X, Xi S, Jing H, Yuan J, Fu Z, Zhao H. Trends in global, regional and national incidence of pneumoconiosis caused by different aetiologies: an analysis from the Global Burden of Disease Study 2017. Occup Environ Med. 2020;77(6):407–14.CrossRef Shi P, Xing X, Xi S, Jing H, Yuan J, Fu Z, Zhao H. Trends in global, regional and national incidence of pneumoconiosis caused by different aetiologies: an analysis from the Global Burden of Disease Study 2017. Occup Environ Med. 2020;77(6):407–14.CrossRef
13.
go back to reference Collaborators GBDCRD: Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020; 8(6):585–96. Collaborators GBDCRD: Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020; 8(6):585–96.
14.
go back to reference Li X, Cao X, Guo M, Xie M, Liu X. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ. 2020;368:m234.CrossRef Li X, Cao X, Guo M, Xie M, Liu X. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ. 2020;368:m234.CrossRef
15.
go back to reference Xie M, Liu X, Cao X, Guo M, Li X. Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017. Respir Res. 2020;21(1):49.CrossRef Xie M, Liu X, Cao X, Guo M, Li X. Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017. Respir Res. 2020;21(1):49.CrossRef
16.
go back to reference Wang D, Liang R, Yang M, Ma J, Li W, Mu M, Xiao Y, Feng X, Dong C, Yu L, et al. Incidence and disease burden of coal workers’ pneumoconiosis worldwide, 1990–2019: evidence from the Global Burden of Disease Study 2019. Eur Respir J. 2021;58(5):2101669.CrossRef Wang D, Liang R, Yang M, Ma J, Li W, Mu M, Xiao Y, Feng X, Dong C, Yu L, et al. Incidence and disease burden of coal workers’ pneumoconiosis worldwide, 1990–2019: evidence from the Global Burden of Disease Study 2019. Eur Respir J. 2021;58(5):2101669.CrossRef
17.
go back to reference Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef
18.
go back to reference Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1204–22. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1204–22.
19.
go back to reference Collaborators GBDD. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1160–203.CrossRef Collaborators GBDD. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1160–203.CrossRef
20.
go back to reference Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28(29):3670–82.CrossRef Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28(29):3670–82.CrossRef
21.
go back to reference Ndlovu N, Richards G, Vorajee N, Murray J. Silicosis and pulmonary tuberculosis in deceased female South African miners. Occup Med (Lond). 2019;69(4):272–8.CrossRef Ndlovu N, Richards G, Vorajee N, Murray J. Silicosis and pulmonary tuberculosis in deceased female South African miners. Occup Med (Lond). 2019;69(4):272–8.CrossRef
22.
go back to reference Jones RM. Artificial stone silicosis: need for improved controls. Ann Work Expo Health. 2022;66(2):137–8.CrossRef Jones RM. Artificial stone silicosis: need for improved controls. Ann Work Expo Health. 2022;66(2):137–8.CrossRef
23.
go back to reference Henneberger PK, Weissman DN. Old adversaries in new places. Occup Environ Med. 2018;75(1):1–2.CrossRef Henneberger PK, Weissman DN. Old adversaries in new places. Occup Environ Med. 2018;75(1):1–2.CrossRef
24.
go back to reference Kerget B, Araz O, Yilmazel Ucar E, Karaman A, Calik M, Alper F, Akgun M. Female workers’ silicosis diagnosis delayed due to gender bias. Occup Med (Lond). 2019;69(3):219–22.CrossRef Kerget B, Araz O, Yilmazel Ucar E, Karaman A, Calik M, Alper F, Akgun M. Female workers’ silicosis diagnosis delayed due to gender bias. Occup Med (Lond). 2019;69(3):219–22.CrossRef
25.
go back to reference Mazurek JM, Wood JM, Schleiff PL, Weissman DN. Surveillance for silicosis deaths among persons aged 15–44 years: United States, 1999–2015. MMWR Morb Mortal Wkly Rep. 2017;66(28):747–52.CrossRef Mazurek JM, Wood JM, Schleiff PL, Weissman DN. Surveillance for silicosis deaths among persons aged 15–44 years: United States, 1999–2015. MMWR Morb Mortal Wkly Rep. 2017;66(28):747–52.CrossRef
26.
go back to reference Ferrante P. Costs of asbestosis and silicosis hospitalization in Italy (2001–2018): Costs of asbestosis and silicosis hospitalization. Int Arch Occup Environ Health. 2021;94(4):763–71.CrossRef Ferrante P. Costs of asbestosis and silicosis hospitalization in Italy (2001–2018): Costs of asbestosis and silicosis hospitalization. Int Arch Occup Environ Health. 2021;94(4):763–71.CrossRef
27.
go back to reference Menendez-Navarro A, Cavalin C, Garcia-Gomez M, Gherasim A: The re-emergence of silicosis as an occupational disease in Spain, 1990–2019. Rev Esp Salud Publica. 2021; 95. Menendez-Navarro A, Cavalin C, Garcia-Gomez M, Gherasim A: The re-emergence of silicosis as an occupational disease in Spain, 1990–2019. Rev Esp Salud Publica. 2021; 95.
28.
go back to reference Martínez González C, Prieto González A, García Alfonso L, Fernández Fernández L, Moreda Bernardo A, Fernández Álvarez R, Rolle-Sóñora V, Ruano Raviña A, Casan Clarà P. Silicosis in artificial quartz conglomerate workers. Arch Bronconeumol (Engl Ed). 2019;55(9):459–64.CrossRef Martínez González C, Prieto González A, García Alfonso L, Fernández Fernández L, Moreda Bernardo A, Fernández Álvarez R, Rolle-Sóñora V, Ruano Raviña A, Casan Clarà P. Silicosis in artificial quartz conglomerate workers. Arch Bronconeumol (Engl Ed). 2019;55(9):459–64.CrossRef
29.
go back to reference Austin EK, James C, Tessier J. Early detection methods for silicosis in Australia and internationally: a review of the literature. Int J Environ Res Public Health. 2021;18(15):8123.CrossRef Austin EK, James C, Tessier J. Early detection methods for silicosis in Australia and internationally: a review of the literature. Int J Environ Res Public Health. 2021;18(15):8123.CrossRef
30.
go back to reference Cavalin C, Lescoat A, Ballerie A, Belhomme N, Jego P, Jouneau S, Lecureur V, Lederlin M, Paris C, Rosental PA. Beyond silicosis, is the world failing on silica hazards? Lancet Respir Med. 2019;7(8):649–50.CrossRef Cavalin C, Lescoat A, Ballerie A, Belhomme N, Jego P, Jouneau S, Lecureur V, Lederlin M, Paris C, Rosental PA. Beyond silicosis, is the world failing on silica hazards? Lancet Respir Med. 2019;7(8):649–50.CrossRef
31.
go back to reference Poinen-Rughooputh S, Rughooputh MS, Guo Y, Rong Y, Chen W. Occupational exposure to silica dust and risk of lung cancer: an updated meta-analysis of epidemiological studies. BMC Public Health. 2016;16(1):1137.CrossRef Poinen-Rughooputh S, Rughooputh MS, Guo Y, Rong Y, Chen W. Occupational exposure to silica dust and risk of lung cancer: an updated meta-analysis of epidemiological studies. BMC Public Health. 2016;16(1):1137.CrossRef
32.
go back to reference Banks LDE, Houston FS, Jindal SK. Can we alter the natural history of silicosis? Chest. 2015;148(3):574–6.CrossRef Banks LDE, Houston FS, Jindal SK. Can we alter the natural history of silicosis? Chest. 2015;148(3):574–6.CrossRef
33.
go back to reference Commentary for JOEM Forum-Silicosis. Then and now. J Occup Environ Med. 2017;59(2):222–33.CrossRef Commentary for JOEM Forum-Silicosis. Then and now. J Occup Environ Med. 2017;59(2):222–33.CrossRef
34.
go back to reference Bragazzi NL, Dini G, Toletone A, Brigo F, Durando P. Leveraging big data for exploring occupational diseases-related interest at the level of scientific community, media coverage and novel data streams: the example of silicosis as a pilot study. PLOS ONE. 2016;11(11):e0166051.CrossRef Bragazzi NL, Dini G, Toletone A, Brigo F, Durando P. Leveraging big data for exploring occupational diseases-related interest at the level of scientific community, media coverage and novel data streams: the example of silicosis as a pilot study. PLOS ONE. 2016;11(11):e0166051.CrossRef
35.
go back to reference Schleiff PL, Mazurek JM, Reilly MJ, Rosenman KD, Yoder MB, Lumia ME, Worthington K. Surveillance for silicosis: Michigan and New Jersey, 2003–2011. MMWR Morb Mortal Wkly Rep. 2016;63(55):73–8.CrossRef Schleiff PL, Mazurek JM, Reilly MJ, Rosenman KD, Yoder MB, Lumia ME, Worthington K. Surveillance for silicosis: Michigan and New Jersey, 2003–2011. MMWR Morb Mortal Wkly Rep. 2016;63(55):73–8.CrossRef
Metadata
Title
Global and national burden and trends of mortality and disability-adjusted life years for silicosis, from 1990 to 2019: results from the Global Burden of Disease study 2019
Authors
Shimin Chen
Miao Liu
Fei Xie
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Silicosis
Published in
BMC Pulmonary Medicine / Issue 1/2022
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-022-02040-9

Other articles of this Issue 1/2022

BMC Pulmonary Medicine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.